Google took a hit from the strong dollar, but better expense control boosted first-quarter profit margins, lifting the company’s shares.
High expectations for Biogen’s multiple-sclerosis drug are a significant obstacle for the stock.
PepsiCo Inc. it will remove aspartame from Diet Pepsi in the U.S. and replace it with sucralose, another artificial sweetener, in a bid to reverse plunging sales.
American companies continue to curtail spending on big-ticket products such as equipment and machinery, the latest sign the U.S. economy got clobbered in the first quarter by troubles at home and abroad.
The author of “The Sculptor” on the utility of laptop tents, old iPads and travel mugs.
Box’s founders paid a steep price for venture capital the cloud-software firm got on the way to an IPO.
U.K. pharmaceutical company AstraZeneca is doing deals to help bolster near-term revenues, potentially at the cost of future earnings.
Talks in Riga brought no joy on Greece. Markets face persistent uncertainty as a result.
Confidence among German companies improved to its highest level in nearly a year, extending a strong start to 2015 for Europe’s biggest economy.
Chevron Phillips Chemical is one of many companies around the country pushing programs to help close a skills gap that is weighing on the middle class and entrenching a growing income inequality.